Objective To analyzed the
therapeutic effect of
piperacillin sodium and sulbactum
sodium(PIP/SBT)for
injection in
children bronchopneumonia.
Methods 162
bronchopneumonia children who were admitted to
pediatrics department during January 2014 to January 2016 were enrolled for this study and randomly divided into the
observation group and the
control group.The
observation group received
piperacillin sodium and sulbactum
sodium therapy, while the
control group received
azithromycin.The symptom scores of coughing,
wheezing,
wheezing sound and the difficulty of expectoration in the 3rd day and 7th day were compared.The
therapeutic effect of the two groups were evaluated.Results The
observation group and the
control group could both improve the symptom scores of coughing,
wheezing,
wheezing sound and the difficulty of expectoration in the 3rd day and 7th day, while the scores of
observation group were significantly lower than the control ones.And the effective rate of
observation group(97.5%)was significantly higher than the control one(90.1%).Conclusion
Piperacillin sodium and sulbactum
sodium(PIP/SBT)for
injection had significantly clinical effect applying in
children bronchopneumonia treatment, which was worthy of further popularization and application.